Philadelphia, PA | July 2021 – RatnerPrestia’s James Matthew Gould will be presenting an interactive case study in the pharmaceutical patent litigation space on July 22, 2021, at the American Conference Institute‘s upcoming 19th Advanced Summit on Life Sciences Patents. His topic will focus on allegations of patent infringement when generic companies carve out patented indications […]
Read more
Washington, D.C. | April 2021 – RP CEO Jonathan H. Spadt, will be moderating a set of important and timely exchanges on April 29 as a part of the on-going Global Series meetings of the Federal Circuit Bar Association. The virtual meeting, scheduled for 11:00 a.m. EDT – 12:30 p.m. EDT, will open with a […]
Read more
Washington, D.C. | March 2021 – RatnerPrestia is honored to have been selected as a Member Company of the Board of Directors of the German American Business Council (GABC). RP has been represented by its CEO, Jonathan H. Spadt, as a Leadership Member of the GABC since 2010. Founded as an initiative of the Embassy […]
Read more
Washington, D.C. | March 2021 – RatnerPrestia is pleased to welcome Ben Xiaobin You to the firm in the District of Columbia Office. As an IP attorney, Ben will focus on electrical and mechanical technologies as it relates to the building, maintaining and enforcing patents for inventions. As a patent prosecutor before the United States […]
Read more
Philadelphia, PA | January 2021 – RatnerPrestia litigators Christopher Blaszkowski and Andrew Koopman recently prevailed in an inter partes review proceeding in which they represented Petitioner Remediation Products, Inc. The final written decision, which issued on January 15, cancelled every claim of U.S. Patent No. 7,531,709 (“the ‘709 Patent”). The ‘709 Patent “relates to an […]
Read more
Philadelphia, PA | January 2021 – Robert A. Esposito of RatnerPrestia will co-present on the topic of “Artificial Intelligence and the Related Issues of Patentability, Inventorship, and Trade Secrets.” for The Benjamin Franklin American Inn of Court on Thursday, January 21st at 6PM. A group will present the challenges that may be faced when trying […]
Read more
Philadelphia, PA | November 2020 – RatnerPrestia CEO Jonathan H. Spadt will be presenting on SEP/FRAND issues at the next virtual meeting of the Philadelphia Intellectual Property Law Association (PIPLA) on November 18, 2020. Spadt’s remarks will summarize the recent Judgment of the UK Supreme Court in Unwired Planet v. Huawei et al., and offer […]
Read more
Philadelphia, PA | October 2020 – RatnerPrestia’s James Matthew Gould will be speaking on “Recent Trends in ANDA Pharmaceutical Patent Litigation” at a virtual CLE meeting of the Philadelphia Intellectual Property Law Association on Wednesday, October 21, 2020 at 5:30 pm. The topic will focus on the recent Federal Circuit opinion in GlaxoSmithKline v. Teva […]
Read more
Philadelphia, PA | October 2020 – Robert A. Esposito of RatnerPrestia will co-present on the topic of “COVID Diagnosis Patent Eligibility With Respect to Recent Subject Matter Eligibility Cases and USPTO Guidance” on Thursday, October 15th at 6PM. Robert will be speaking on the subject matter eligibility of claims from recently published COVID focused patent […]
Read more
Philadelphia, PA | September 2020 – Jonathan H. Spadt, CEO & President of RatnerPrestia, will appear as a panelist on the 2020 Global Series Webcast, “SEP/FRAND Challenges: Unwired Planet: Implications and Strategies” on Friday, October 16, 2020 at 10:00 a.m. EDT. Hosted by The Federal Circuit Bar Association, the panel will explore the impacts of the decision, […]
Read more
Previous Entries
